{"database": "lobbying", "table": "lobbying_activities", "rows": [[3192766, "29e25151-6bec-4fe0-b9c4-3c272b8dd755", "Q2", "2359 STRATEGIES", 401106114, "TRAVERE THERAPEUTICS", 2024, "second_quarter", "MED", "Rare kidney disease", "HOUSE OF REPRESENTATIVES,SENATE", 12000, null, 0, 0, "2024-07-15T17:54:19-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3192766"], "units": {}, "query_ms": 0.3706889692693949, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}